Dr. Marco Bottaro
Managing Director of Eucardia with over twenty years’ background in the life sciences and venture capital industries. He has developed a broad business management experience working in the biomedical industry as a researcher, product manager and marketing & sales manager (DiaSorin, Aastrom Biosciences), as well as for life tech-companies as a strategic advisor, and seed- and venture capital firms as a venture partner (TTVenture, SeedLab, M31).
Eucardia develops a new patented cardiac medical device intended to provide a simple, quick and cost effective solution to treat patients affected by advanced heart failure.
Eucardia is an Italian startup company incorporated in 2013, based in Milano with an operative unit located in the biomedical district of Mirandola, close to Modena city, and a widespread network of collaborations in Europe. Eucardia develops the Heart Damper, a proprietary innovative minimally invasive implantable class III cardiac medical device intended to provide a simple, quick and cost effective solution to treat patients affected by advanced heart failure, giving them a longer and better life perspective, at the same time reducing healthcare costs for their assistance.
cardiovascular / medical device / heart failure /
private company (start-up/sme) with an innovative product, technology or service
life sciences / medtech
Registration & Profiling Platform v1.3.6246.21300
Copyright ©1998-2017 Europe Unlimited - All rights reserved